1. Home
  2. SLP vs PFN Comparison

SLP vs PFN Comparison

Compare SLP & PFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLP
  • PFN
  • Stock Information
  • Founded
  • SLP 1996
  • PFN 2004
  • Country
  • SLP United States
  • PFN United States
  • Employees
  • SLP N/A
  • PFN N/A
  • Industry
  • SLP EDP Services
  • PFN Finance/Investors Services
  • Sector
  • SLP Technology
  • PFN Finance
  • Exchange
  • SLP Nasdaq
  • PFN Nasdaq
  • Market Cap
  • SLP 675.9M
  • PFN 636.0M
  • IPO Year
  • SLP 1997
  • PFN N/A
  • Fundamental
  • Price
  • SLP $18.32
  • PFN $7.44
  • Analyst Decision
  • SLP Buy
  • PFN
  • Analyst Count
  • SLP 7
  • PFN 0
  • Target Price
  • SLP $40.40
  • PFN N/A
  • AVG Volume (30 Days)
  • SLP 571.2K
  • PFN 331.7K
  • Earning Date
  • SLP 07-14-2025
  • PFN 01-01-0001
  • Dividend Yield
  • SLP 0.32%
  • PFN 11.66%
  • EPS Growth
  • SLP N/A
  • PFN N/A
  • EPS
  • SLP 0.36
  • PFN N/A
  • Revenue
  • SLP $78,564,000.00
  • PFN N/A
  • Revenue This Year
  • SLP $27.66
  • PFN N/A
  • Revenue Next Year
  • SLP $6.75
  • PFN N/A
  • P/E Ratio
  • SLP $51.73
  • PFN N/A
  • Revenue Growth
  • SLP 21.49
  • PFN N/A
  • 52 Week Low
  • SLP $16.72
  • PFN $5.94
  • 52 Week High
  • SLP $49.05
  • PFN $7.58
  • Technical
  • Relative Strength Index (RSI)
  • SLP 29.54
  • PFN 65.93
  • Support Level
  • SLP $16.78
  • PFN $7.33
  • Resistance Level
  • SLP $17.70
  • PFN $7.40
  • Average True Range (ATR)
  • SLP 1.15
  • PFN 0.05
  • MACD
  • SLP -0.00
  • PFN 0.01
  • Stochastic Oscillator
  • SLP 14.61
  • PFN 75.00

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About PFN PIMCO Income Strategy Fund II

PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.

Share on Social Networks: